Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 62.817 a 62.836 di 83.661
Titolo Data di pubblicazione Autore(i) File
Re-use of steel slags in hydraulically bound mixtures for road pavements: a laboratory analysis 1-gen-2009 Pasetto, M; Baldo, Nicola
Re2I2(CO)6(Se7), a Coordination Compound of Elemental Selenium with a Transition Metal: a Solution- and Solid-State Study 1-gen-1994 A., Bacchi; Baratta, Walter; F., Calderazzo; F., Marchetti; G., Pelizzi
RE: "Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers" 1-gen-2011 Fagotti, A.; Vizzielli, G.; Scambia, G.
Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation 1-gen-2020 Cimadamore, A.; Cheng, L.; Scarpelli, M.; Lopez-Beltran, A.; Mollica, V.; Montironi, R.; Massari, F.
Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4:182-91: Image Analysis, Nuclear Abnormality Index, and Pattern Recognition Analysis 1-gen-2021 Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Montironi, R.
Re: Condylectomy: treatment of recurrent unilateral dislocation of the temporomandibular joint in a patient with Ehlers-Danlos syndrome 1-gen-2019 Sembronio, S.; Tel, A.; Robiony, M.
Re: Friederike Haidl, David Pfister, Axel Heidenreich. Re: Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. Mordasini L, Hechelhammer L, Diener PA, et al. J Vasc Interv Radiol 2018;29:589–97. Eur Urol 2018;74:525–6: Could Morphologic Changes in Periprostatic Arteries Have an Influence on Prostatic Artery Embolization? 1-gen-2019 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
Re: George J. Netto, Mahul B. Amin, Eva M. Compérat, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.015 1-gen-2023 Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667–75: How Does Circulating DNA Reach the Blood Stream? 1-gen-2019 Montironi, R.; Cheng, L.; Scarpelli, M.; Cimadamore, A.; Montorsi, F.; Lopez-Beltran, A.
Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560–9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step? 1-gen-2018 Di Nunno, V.; Santoni, M.; Cimadamore, A.; Battelli, N.; Massari, F.
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors 1-gen-2018 Santoni, Matteo; Piva, Francesco; Conti, Alessandro; Santoni, Angela; Cimadamore, Alessia; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo
Re: Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-institutional Randomized Trial Comparing Robot Versus Open Radical Cystectomy 1-gen-2020 Giannarini, G.; Valotto, C.; Ficarra, V.
Re: High- and Low-Fat Dairy Intake, Recurrence, and Mortality After Breast Cancer Diagnosis 1-gen-2013 Zucchetto, A; Franceschi, S; Polesel, J; Parpinel, Maria; Dal Maso, L.
Re: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy 1-gen-2021 Santoni, M.; Massari, F.; Santoni, G.; Cimadamore, A.; Montironi, R.; Battelli, N.
Re: Isabel Rauscher, Charlotte Düwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018;73:656–61: Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists 1-gen-2018 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
Re: Lorenzo Marconi, Thomas Stonier, Rafael Tourinho-Barbosa, et al. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol 2019;76:27–30: Morphologic Documentation from Didactic Cases of Large-format Histology 1-gen-2020 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
Re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019;76:871 1-gen-2020 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Galosi, A. B.; Montorsi, F.; Montironi, R.
Re: Martha Boone. The Unfettered Urologist. What I Never Had Time to Tell You in a Fifteen Minute Office Visit. New York, NY: Morgan James Publishing; 2023 1-gen-2024 Montironi, R.; Cheng, L.; Cimadamore, A.; Lopez-Beltran, A.
Re: Multi-institutional Re-evaluation of Prognostic Factors in Chromophobe Renal Cell Carcinoma: Proposal of a Novel Two-tiered Grading Scheme 1-gen-2020 Cimadamore, A; Cheng, L; Ohashi, R; Scarpelli, M; Lopez-Beltran, A; Moch, H; Montironi, R
Re: Nipple reconstruction: the top hat technique 1-gen-2006 De Biasio, F.; Nadalig, B.; Salemi, S.; Parodi, Pier Camillo
Mostrati risultati da 62.817 a 62.836 di 83.661
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile